https://www.newslocker.com/en-uk/profession/pharmaceutical-industry/en-ukCopyright (C) 2026 newslocker.comMon, 20 Jul 2026 17:59:00 +0200https://www.newslocker.com/en-uk/profession/pharmaceutical-industry/2017-to-2022-saw-more-than-doubling-in-use-of-glp-1-receptor-agonists/Mon, 20 Jul 2026 17:59:00 +0200https://www.newslocker.com/en-uk/profession/pharmaceutical-industry/2017-to-2022-saw-more-than-doubling-in-use-of-glp-1-receptor-agonists/https://www.newslocker.com/en-uk/profession/pharmaceutical-industry/globally-youths-not-eating-enough-healthy-plant-based-foods/Mon, 20 Jul 2026 17:56:00 +0200https://www.newslocker.com/en-uk/profession/pharmaceutical-industry/globally-youths-not-eating-enough-healthy-plant-based-foods/https://www.newslocker.com/en-uk/profession/pharmaceutical-industry/review-shows-most-obesity-drugs-do-not-aid-quality-of-life-heart-health/Mon, 20 Jul 2026 17:50:00 +0200https://www.newslocker.com/en-uk/profession/pharmaceutical-industry/review-shows-most-obesity-drugs-do-not-aid-quality-of-life-heart-health/https://www.newslocker.com/en-uk/profession/pharmaceutical-industry/four-zone-scleral-lens-improves-visual-performance-for-irregular-corneas/Mon, 20 Jul 2026 17:45:00 +0200https://www.newslocker.com/en-uk/profession/pharmaceutical-industry/four-zone-scleral-lens-improves-visual-performance-for-irregular-corneas/https://www.newslocker.com/en-uk/profession/pharmaceutical-industry/individuals-across-races-and-ethnicities-report-psoriasis-as-a-considerable-burden/Mon, 20 Jul 2026 17:41:00 +0200https://www.newslocker.com/en-uk/profession/pharmaceutical-industry/individuals-across-races-and-ethnicities-report-psoriasis-as-a-considerable-burden/https://www.newslocker.com/en-uk/profession/pharmaceutical-industry/2015-to-2023-saw-decline-in-health-care-associated-infections-in-the-us/Fri, 17 Jul 2026 22:39:00 +0200https://www.newslocker.com/en-uk/profession/pharmaceutical-industry/2015-to-2023-saw-decline-in-health-care-associated-infections-in-the-us/https://www.newslocker.com/en-uk/profession/pharmaceutical-industry/more-weight-loss-reported-with-dexamphetamine-versus-methylphenidate-for-adhd/Fri, 17 Jul 2026 22:35:00 +0200https://www.newslocker.com/en-uk/profession/pharmaceutical-industry/more-weight-loss-reported-with-dexamphetamine-versus-methylphenidate-for-adhd/https://www.newslocker.com/en-uk/profession/pharmaceutical-industry/aaic-blood-test-detecting-p-tau217-levels-can-predict-progression-to-cognitive-impairment/Fri, 17 Jul 2026 17:42:00 +0200https://www.newslocker.com/en-uk/profession/pharmaceutical-industry/aaic-blood-test-detecting-p-tau217-levels-can-predict-progression-to-cognitive-impairment/https://www.newslocker.com/en-uk/profession/pharmaceutical-industry/aaic-blood-based-biomarkers-for-alzheimer-disease-improve-accuracy-of-diagnosis/Fri, 17 Jul 2026 17:30:00 +0200https://www.newslocker.com/en-uk/profession/pharmaceutical-industry/aaic-blood-based-biomarkers-for-alzheimer-disease-improve-accuracy-of-diagnosis/https://www.newslocker.com/en-uk/profession/pharmaceutical-industry/peptide-vaccine-targeting-kras-mutations-promising-for-pancreatic-ductal-adenocarcinoma/Fri, 17 Jul 2026 17:21:00 +0200https://www.newslocker.com/en-uk/profession/pharmaceutical-industry/peptide-vaccine-targeting-kras-mutations-promising-for-pancreatic-ductal-adenocarcinoma/https://www.newslocker.com/en-uk/profession/pharmaceutical-industry/seniors-undergoing-high-risk-emergency-general-surgery-have-fewer-healthy-days-at-home/Fri, 17 Jul 2026 17:14:00 +0200https://www.newslocker.com/en-uk/profession/pharmaceutical-industry/seniors-undergoing-high-risk-emergency-general-surgery-have-fewer-healthy-days-at-home/https://www.newslocker.com/en-uk/profession/pharmaceutical-industry/tobacco-treatment-program-effective-in-oncology-settings/Fri, 17 Jul 2026 17:00:00 +0200https://www.newslocker.com/en-uk/profession/pharmaceutical-industry/tobacco-treatment-program-effective-in-oncology-settings/https://www.newslocker.com/en-uk/profession/pharmaceutical-industry/odds-of-stroke-lower-among-black-individuals-who-have-immigrated/Thu, 16 Jul 2026 23:49:00 +0200https://www.newslocker.com/en-uk/profession/pharmaceutical-industry/odds-of-stroke-lower-among-black-individuals-who-have-immigrated/https://www.newslocker.com/en-uk/profession/pharmaceutical-industry/new-cancer-cases-predicted-to-increase-to-344-million-by-2050/Thu, 16 Jul 2026 23:46:00 +0200https://www.newslocker.com/en-uk/profession/pharmaceutical-industry/new-cancer-cases-predicted-to-increase-to-344-million-by-2050/https://www.newslocker.com/en-uk/profession/pharmaceutical-industry/about-one-third-of-women-35-years-and-older-report-perimenopause-uncertainty/Thu, 16 Jul 2026 18:16:00 +0200https://www.newslocker.com/en-uk/profession/pharmaceutical-industry/about-one-third-of-women-35-years-and-older-report-perimenopause-uncertainty/https://www.newslocker.com/en-uk/profession/pharmaceutical-industry/increase-in-smoking-unlikely-with-very-low-nicotine-cigarettes/Thu, 16 Jul 2026 18:13:00 +0200https://www.newslocker.com/en-uk/profession/pharmaceutical-industry/increase-in-smoking-unlikely-with-very-low-nicotine-cigarettes/https://www.newslocker.com/en-uk/profession/pharmaceutical-industry/high-dose-intravenous-vitamin-c-may-benefit-trauma-patients/Thu, 16 Jul 2026 18:07:00 +0200https://www.newslocker.com/en-uk/profession/pharmaceutical-industry/high-dose-intravenous-vitamin-c-may-benefit-trauma-patients/https://www.newslocker.com/en-uk/profession/pharmaceutical-industry/glp-1-receptor-agonist-use-does-not-increase-insulin-discontinuation-with-type-2-diabetes/Thu, 16 Jul 2026 18:04:00 +0200https://www.newslocker.com/en-uk/profession/pharmaceutical-industry/glp-1-receptor-agonist-use-does-not-increase-insulin-discontinuation-with-type-2-diabetes/https://www.newslocker.com/en-uk/profession/pharmaceutical-industry/global-findings-indicate-breast-cancer-and-a-fib-incidence-frequently-overlap/Thu, 16 Jul 2026 18:00:00 +0200https://www.newslocker.com/en-uk/profession/pharmaceutical-industry/global-findings-indicate-breast-cancer-and-a-fib-incidence-frequently-overlap/https://www.newslocker.com/en-uk/profession/pharmaceutical-industry/glp-1-receptor-agonist-use-linked-to-higher-risk-for-ischemic-optic-neuropathy/Thu, 16 Jul 2026 17:55:00 +0200https://www.newslocker.com/en-uk/profession/pharmaceutical-industry/glp-1-receptor-agonist-use-linked-to-higher-risk-for-ischemic-optic-neuropathy/